Stay updated on Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial

Sign up to get notified when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 to the study record versions. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T17:25:41.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    This update changes only the revision history: a new Revision v3.3.2 was added and Revision v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:24:44.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The operating-status notice about government funding was removed from the page, and the standard study information is now displayed.
    Difference
    0.8%
    Check dated 2025-11-17T18:51:56.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-11-03T13:16:55.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and updated version to v3.2.0; removed the previous version tag v3.1.0.
    Difference
    13%
    Check dated 2025-10-06T01:53:17.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.3%
    Check dated 2025-09-28T23:28:35.000Z thumbnail image

Stay in the know with updates to Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.